Designs custom microbes for a variety of industries including healthcare and agriculture.
Ginkgo Bioworks Holdings, Inc., based in Boston, Massachusetts, is a leader in the field of cell programming technology. The company and its subsidiaries specialize in developing platforms that allow for the programming of cells, enabling them to produce a wide array of products ranging from innovative therapeutics to food ingredients and sustainable chemicals derived from petroleum. Their versatile platform serves diverse industries including specialty chemicals, agriculture, food production, consumer goods, and pharmaceuticals, contributing to advancements in bioengineering across various sectors.
In addition to their core capabilities in cell programming, Ginkgo Bioworks has established strategic collaborations to expand its technological reach and product offerings. Notably, the company has partnered with Selecta Biosciences, Inc. to advance the ImmTOR technology platform, enhancing capabilities in therapeutic development and immune modulation. These partnerships underscore Ginkgo Bioworks' commitment to leveraging cutting-edge biological engineering to address complex challenges and deliver impactful solutions.
Founded in 2008, Ginkgo Bioworks has grown into a pioneering force in biotechnology, driving innovation through its robust research and development initiatives. With its headquarters in Boston, the company continues to lead the charge in harnessing the power of biology to create sustainable and transformative products that benefit industries and society as a whole.